NEWS  Apple  December 18, 2023  Reading time: 3 Minute(s)

Max (RS editor)

Apple has announced its decision to halt sales of the newly launched Apple Watch Series 9 and the Apple Watch Ultra 2 in the United States. The decision, set to take effect later this week, is a preemptive response to an ongoing patent dispute centered around the innovative blood oxygen sensor technology embedded in these smartwatches.

The US ITC Ruling

The roots of this decision lie in a recent order from the US International Trade Commission (US ITC). In October, the US ITC ruled that Apple had infringed on two patents owned by medical technology company Masimo. These patents specifically relate to the light-based pulse oximeter feature, a key component of the Apple Watch's health monitoring capabilities.

This ruling initiated a 60-day Presidential Review Period, during which the Biden administration has the authority to veto the potential ban on the sales and import of the disputed Apple Watch models. As the December 25 deadline approaches and with no intervention from the administration thus far, Apple has proactively chosen to halt sales.

Apple's Stance and Legal Measures

In response to the US ITC order, Apple expressed its disagreement and highlighted its commitment to providing users with cutting-edge health, wellness, and safety features. The tech giant is actively pursuing a range of legal and technical options to ensure the continued availability of the Apple Watch to its customers.

If the Biden administration decides not to veto the ITC decision, Apple's next step involves appealing the ruling with the US Court of Appeals for the Federal Circuit. The appeal is scheduled to be filed on December 26, the day after the veto deadline expires. Until the appeals court reaches a decision, the sales and import ban on the smartwatches will remain in effect.

Potential Solutions for Apple

While facing this challenge, Apple has several potential avenues for resolution. Negotiating a settlement and licensing agreement with Masimo is one option, as is making firmware adjustments to disable the features infringing on the patent. However, the effectiveness of software restrictions in satisfying patent conditions remains uncertain.

Impact on Consumers

For consumers eager to purchase the latest Apple Watch models, the window is closing rapidly. Online sales through Apple.com will cease on December 21, and Apple retail locations will follow suit after December 24. Third-party retailers like Amazon and Best Buy may still have units available until stocks run out. Importantly, existing Apple Watch owners with blood oxygen sensors introduced with the Series 6 are unaffected by this development.

As the deadline looms and the fate of the Apple Watch Series 9 and Apple Watch Ultra 2 hangs in the balance, the tech community watches closely. Apple's strategic decisions in the coming weeks, along with potential legal resolutions, will determine the future availability of these innovative smartwatches in the US market.

As the current situation unfolds this could be the right time to get an Apple Watch at bargain price!

Check Apple Watch Series 9 Prices on Amazon:

Check Apple Watch Ultra 2 Prices on Amazon:

 IMAGES CREDITS: APPLE